Concord Wealth Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11K Buy
+54
New +$1.24K ﹤0.01% 769
2026
Q1
Sell
-54
Closed -$637 286
2025
Q4
$637 Hold
54
﹤0.01% 740
2025
Q3
$855 Sell
54
-12
-18% -$174 ﹤0.01% 749
2025
Q2
$756 Hold
66
﹤0.01% 769
2025
Q1
$893 Buy
66
+12
+22% +$199 ﹤0.01% 738
2024
Q4
$913 Hold
54
﹤0.01% 809
2024
Q3
$1.1K Hold
54
﹤0.01% 820
2024
Q2
$1.22K Hold
54
﹤0.01% 710
2024
Q1
$1.42K Hold
54
﹤0.01% 775
2023
Q4
$1.7K Hold
54
﹤0.01% 730
2023
Q3
$1.51K Hold
54
﹤0.01% 905
2023
Q2
$1.99K Buy
+54
New +$1.65K ﹤0.01% 867

Other funds holding CC

Concord Wealth Partners's CC Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Chemours (CC) in Q2 2026: 54 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #769 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in CC as recently as Q4 2025.

Concord Wealth Partners first reported a position in CC in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.99K in Q2 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Concord Wealth Partners held 54 shares of Chemours worth $1.11K as of Q2 2026.
  • Chemours was a new Concord Wealth Partners position in Q2 2026.
  • Chemours made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #769 holding.
  • Concord Wealth Partners first reported a position in Chemours in Q2 2023 and has held it in 12 quarters since.
  • Concord Wealth Partners's Chemours position peaked at $1.99K in Q2 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.